A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma
Methylprednisolone is recommended as the front-line therapy for radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma. However, some patients fail to benefit from methylpredniso...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Xiaohuang Zhuo, Huiying Zhao, Meiwei Chen, Youqing Mu, Yi Li, Jinhua Cai, Honghong Li, Yongteng Xu and Yamei Tang Tags: Research Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Methylprednisolone | Nasopharyngeal Cancer | Neurology